Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Oct-24 8:06 PM View:  | Akero Therapeutics, Inc. (AKRO) | 14-Oct-24 | Option Exercise | 40,000 | $21.09 | $843,600.00 | 14% 286.29K to 326.29K | (7%) |
| 16-Oct-24 8:06 PM View: | Akero Therapeutics, Inc. (AKRO) | 14-Oct-24 | Planned Private Option Sale | 40,000 | $30.15 | $1,206,080.00 | (12%) 326.29K to 286.29K | |
| 13-Sep-24 5:16 PM View: | Akero Therapeutics, Inc. (AKRO) | 10-Sep-24 | Private Sale | 568 | $26.18 | $14,870.20 | (< 1%) 296.85K to 296.29K | |
| 05-Sep-24 4:08 PM View: | Akero Therapeutics, Inc. (AKRO) | 03-Sep-24 | Private Sale (Planned) | 5,000 | $26.72 | $133,588.00 | (2%) 301.85K to 296.85K | |
| 13-Jun-24 6:13 PM View: | Akero Therapeutics, Inc. (AKRO) | 11-Jun-24 | Private Sale | 2,516 | $22.64 | $56,964.80 | (< 1%) 313.31K to 310.79K | |
| 05-Jun-24 5:05 PM View: | Akero Therapeutics, Inc. (AKRO) | 03-Jun-24 | Market Sale (Planned) | 5,000 | $19.29 | $96,440.00 | (2%) 318.31K to 313.31K | (2%) |
| 02-May-24 9:07 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-May-24 | Market Sale (Planned) | 5,000 | $20.15 | $100,750.00 | (2%) 323.31K to 318.31K | 2% |
| 03-Apr-24 6:55 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Apr-24 | Private Sale (Planned) | 5,000 | $24.38 | $121,913.00 | (< 1%) 592.01K to 587.01K | |
| 15-Mar-24 4:42 PM View: | Akero Therapeutics, Inc. (AKRO) | 13-Mar-24 | Private Sale | 651 | $28.33 | $18,442.80 | (< 1%) 328.96K to 328.31K | |
| 05-Mar-24 5:16 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Mar-24 | Option Exercise | 83,321 | $0.62 | $51,242.40 | 34% 245.64K to 328.96K | |
| 29-Dec-23 8:30 PM View: | Akero Therapeutics, Inc. (AKRO) | 27-Dec-23 | Option Exercise | 5,414 | $6.36 | $34,433.00 | 2% 245.13K to 250.54K | |
| 29-Dec-23 8:30 PM View: | Akero Therapeutics, Inc. (AKRO) | 27-Dec-23 | Option Sale | 5,414 | $24.00 | $129,936.00 | (2%) 250.54K to 245.13K | |
| 18-Dec-23 8:39 PM View: | Akero Therapeutics, Inc. (AKRO) | 14-Dec-23 | Market Sale | 543 | $20.76 | $11,272.70 | (< 1%) 245.67K to 245.13K | 5% |
| 12-Dec-23 4:43 PM View: | Akero Therapeutics, Inc. (AKRO) | 08-Dec-23 | Grant | 32,497 | -- | -- | 15% 213.18K to 245.67K | |
| 21-Nov-23 5:30 PM View: | Akero Therapeutics, Inc. (AKRO) | 17-Nov-23 | Sale | 30,000 | $14.68 | $440,259.00 | (12%) 243.18K to 213.18K | |
| 04-Oct-23 8:33 PM View: | Akero Therapeutics, Inc. (AKRO) | 02-Oct-23 | Option Exercise | 490 | $21.10 | $10,339.00 | < 1% 243.18K to 243.67K | (7%) |
| 04-Oct-23 8:33 PM View: | Akero Therapeutics, Inc. (AKRO) | 02-Oct-23 | Planned Private Option Sale | 490 | $51.10 | $25,039.00 | (< 1%) 243.67K to 243.18K | |
| 25-Sep-23 8:28 PM View: | Akero Therapeutics, Inc. (AKRO) | 13-Sep-23 | Private Sale (Planned) | 562 | $50.34 | $28,291.10 | (< 1%) 243.74K to 243.18K | |
| 15-Jun-23 9:35 PM View: | Akero Therapeutics, Inc. (AKRO) | 13-Jun-23 | Private Sale (Planned) | 538 | $55.16 | $29,676.10 | (< 1%) 244.28K to 243.74K | |
| 14-Mar-23 4:19 PM View: | Akero Therapeutics, Inc. (AKRO) | 10-Mar-23 | Payment of Exercise | 634 | $43.47 | $27,560.00 | (< 1%) 244.91K to 244.28K | |
| 05-Jan-23 5:56 PM View: | Akero Therapeutics, Inc. (AKRO) | 03-Jan-23 | Option Exercise | 8,777 | $0.62 | $5,397.85 | 4% 244.91K to 253.69K | |
| 05-Jan-23 5:56 PM View: | Akero Therapeutics, Inc. (AKRO) | 03-Jan-23 | Planned Option Sale | 8,777 | $54.64 | $479,560.00 | (3%) 253.69K to 244.91K | |
| 28-Dec-22 6:30 PM View: | Akero Therapeutics, Inc. (AKRO) | 27-Dec-22 | Option Exercise | 12,500 | $6.03 | $75,352.10 | 5% 242.45K to 254.95K | |
| 28-Dec-22 6:30 PM View: | Akero Therapeutics, Inc. (AKRO) | 27-Dec-22 | Planned Option Sale | 12,500 | $49.57 | $619,609.00 | (5%) 254.95K to 242.45K | |
| 13-Dec-22 8:30 PM View: | Akero Therapeutics, Inc. (AKRO) | 09-Dec-22 | Grant | 19,195 | -- | -- | 9% 223.25K to 242.45K | |
| 27-Oct-22 9:25 PM View: | Akero Therapeutics, Inc. (AKRO) | 25-Oct-22 | Option Exercise | 12,500 | $6.36 | $79,500.00 | 6% 223.25K to 235.75K | |
| 27-Oct-22 9:25 PM View: | Akero Therapeutics, Inc. (AKRO) | 25-Oct-22 | Planned Option Sale | 12,500 | $44.72 | $558,944.00 | (5%) 235.75K to 223.25K | |
| 11-Jan-22 4:40 PM View: | Akero Therapeutics, Inc. (AKRO) | 07-Jan-22 | Option Exercise | 27,744 | $0.62 | $17,062.60 | 14% 195.51K to 223.25K | |
| 05-Nov-21 4:17 PM View: | Akero Therapeutics, Inc. (AKRO) | 04-Nov-21 | Market Sale (Planned) | 6,220 | $24.33 | $151,333.00 | (3%) 201.73K to 195.51K | (5%) |
| 05-Nov-21 4:17 PM View: | Akero Therapeutics, Inc. (AKRO) | 03-Nov-21 | Market Sale (Planned) | 18,780 | $24.27 | $455,791.00 | (9%) 220.51K to 201.73K | (6%) |
| 03-Sep-21 4:38 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Sep-21 | Market Sale (Planned) | 12,500 | $24.04 | $300,500.00 | (5%) 233.01K to 220.51K | < 1% |
| 19-Jul-21 4:43 PM View: | Akero Therapeutics, Inc. (AKRO) | 15-Jul-21 | Option Exercise | 9,000 | $0.62 | $5,535.00 | 4% 224.01K to 233.01K | |
| 02-Jun-21 4:06 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Jun-21 | Market Sale (Planned) | 3,055 | $26.24 | $80,151.00 | (1%) 227.06K to 224.01K | (< 1%) |
| 04-May-21 4:06 PM View: | Akero Therapeutics, Inc. (AKRO) | 03-May-21 | Market Sale (Planned) | 3,055 | $30.56 | $93,360.80 | (1%) 230.12K to 227.06K | < 1% |
| 05-Apr-21 5:15 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Apr-21 | Market Sale (Planned) | 3,055 | $28.75 | $87,827.60 | (1%) 233.18K to 230.12K | (3%) |
| 02-Mar-21 5:56 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Mar-21 | Market Sale (Planned) | 3,055 | $30.48 | $93,111.60 | (1%) 236.23K to 233.18K | (< 1%) |
| 02-Feb-21 4:08 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Feb-21 | Market Sale (Planned) | 3,055 | $29.24 | $89,321.50 | (1%) 239.28K to 236.23K | (2%) |
| 11-Jan-21 7:54 PM View: | Akero Therapeutics, Inc. (AKRO) | 08-Jan-21 | Market Option Sale (Planned) | 7,500 | $28.12 | $210,900.00 | (3%) 249.28K to 241.78K | |
| 11-Jan-21 7:54 PM View: | Akero Therapeutics, Inc. (AKRO) | 08-Jan-21 | Market Sale (Planned) | 2,500 | $28.12 | $70,300.00 | (1%) 241.78K to 239.28K | |
| 11-Jan-21 7:54 PM View: | Akero Therapeutics, Inc. (AKRO) | 07-Jan-21 | Option Exercise | 7,500 | $0.62 | $4,612.50 | 3% 241.78K to 249.28K | |
| 06-Jan-21 6:48 PM View: | Akero Therapeutics, Inc. (AKRO) | 04-Jan-21 | Market Sale (Planned) | 3,060 | $25.29 | $77,399.20 | (1%) 244.84K to 241.78K | 5% |
| 09-Dec-20 8:53 PM View: | Akero Therapeutics, Inc. (AKRO) | 30-Jun-20 | Grant | 1,245 | $17.07 | $21,249.70 | < 1% 243.6K to 244.84K | |
| 16-Mar-20 5:51 PM View: | Akero Therapeutics, Inc. (AKRO) | 13-Mar-20 | Option Exercise | 11,117 | $0.62 | $6,836.96 | 5% 232.48K to 243.6K | |
| 10-Jan-20 7:39 PM View: | Akero Therapeutics, Inc. (AKRO) | 10-Jan-20 | Option Exercise | 38,907 | $0.62 | $23,927.80 | 15% 253.58K to 292.48K | |
| 31-Dec-19 4:16 PM View: | Akero Therapeutics, Inc. (AKRO) | 30-Dec-19 | txn.W.title | 667 | -- | -- | < 1% 252.91K to 253.58K |